Skip to main content
J

Jinhe Biotechnology CO.,LTD. — Investor Relations & Filings

Ticker · 002688 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,825 across all filing types
Latest filing 2026-01-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002688

About Jinhe Biotechnology CO.,LTD.

https://www.jinhe.com.cn

Jinhe Biotechnology CO.,LTD. specializes in the research, development, and manufacturing of animal health products and feed additives. The company is a prominent global producer of chlortetracycline (CTC), maintaining extensive production capacity for feed-grade antibiotics. Its diverse product portfolio includes veterinary pharmaceuticals such as salinomycin and monensin, alongside a range of biological products and animal vaccines. Jinhe Biotechnology leverages advanced fermentation technology and integrated research capabilities to provide solutions for the livestock and poultry sectors. The company focuses on improving animal growth performance and disease prevention through standardized production processes and a global distribution network. Its operations span the development of specialized additives and the provision of comprehensive veterinary medical products designed to support large-scale animal husbandry.

Recent filings

Filing Released Lang Actions
关于注销部分募集资金专户的公告
Regulatory Filings
2026-01-21 Chinese
关于金河生物科技股份有限公司二零二六年第一次临时股东会的法律意见书
Regulatory Filings
2026-01-16 Chinese
关于回购注销部分限制性股票减少注册资本暨通知债权人的公告
Regulatory Filings
2026-01-16 Chinese
2026年第一次临时股东会决议的公告
Regulatory Filings
2026-01-16 Chinese
关于归还暂时补充流动资金的闲置募集资金的公告
Regulatory Filings
2026-01-14 Chinese
关于变更保荐机构后重新签订募集资金监管协议的公告
Regulatory Filings
2026-01-08 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.